Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. M. Jablons
A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Classification and Survival Prediction for Early‑stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients
Oncology Letters
Cancer Research
Oncology
Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated With Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
SCD1 Is Associated With Tumor Promotion, Late Stage and Poor Survival in Lung Adenocarcinoma
Oncotarget
Oncology
Molecular Prognostic Factors in Early-Stage Cervical Adenocarcinoma
Polish Journal of Pathology
Medicine
Forensic Medicine
Pathology
DNA Hypomethylation-Related Overexpression of SFN, GORASP2 and ZYG11A Is a Novel Prognostic Biomarker for Early Stage Lung Adenocarcinoma
Oncotarget
Oncology
Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients With Lung Adenocarcinoma
Canadian Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
High Expression of SLC34A2 Is a Favorable Prognostic Marker in Lung Adenocarcinoma Patients
Tumor Biology
Medicine
Cancer Research
Age Is a Prognostic Factor Affecting Survival in Lung Cancer Patients
Oncology Letters
Cancer Research
Oncology
Increased CX3CL1 mRNA Expression Level Is a Positive Prognostic Factor in Patients With Lung Adenocarcinoma
Oncology Letters
Cancer Research
Oncology
